Pancreatic cancer mRNA vaccine shows lasting results in an early trial: Scientists caution that more research is needed, but nearly all of the patients who responded to the personalized vaccine are still alive six years later19. April 2026
News Keebler Health Secures $16M to Scale LLM-Native Risk Adjustment PlatformHealthradar16. April 2026 What You Should Know The Raise: Keebler Health, an LLM-native risk adjustment platform, has raised a $16M Series A funding…
